Wonder drugs for cystic fibrosis, deemed too expensive for the NHS, have been cleared by watchdogs for toddlers. Last week, The Telegraph revealed draft recommendations from the National Institute for Health and Care Excellence (Nice), which said three drugs for the disease are not cost-effective and should not be funded… Continue Reading Toddlers allowed to take wonder drugs for cystic fibrosis
A nutritionist has issued a warning after a TikToker consumed nearly 800mg of caffeine to find out what happens if you take too much of the drug. A student at Boston College took to TikTok to film himself ingesting 790 milligrams of caffeine to find out how too much caffeine… Continue Reading After a student warned what happened to 800 mg of caffeine.
Life-saving cancer drugs are set to be approved at a much faster pace under new plans to take advantage of Brexit freedoms. Cutting red tape, Health Secretary Steve Barclay will today announce a new fast-track process aimed at halving the time it takes to launch research. WATCH HERE: Ben Habib… Continue Reading Brexit boost: Life-saving cancer drugs to be approved much faster in huge shake-up
ROCHESTER Mayo Clinic employees insured by the Mayo Medical Plan will see a new lifetime limit on weight-loss drug coverage starting in 2024. In a letter provided to the Post Bulletin, those prescribed FDA-approved weight loss medications, including Wegovy, Saxenda, Contrave and others, will have the cost of those drugs… Continue Reading Mayo Clinic employee health insurance will cap coverage of weight-loss drugs
The FDA has approved a new weight-loss drug, Eli Lillys Zepbound, sold under the name Mounjaro when it was only a diabetes drug. This is a new competitor to competitor Novo Nordisk’s very popular Wegovy injectable. Although these drugs can quickly help people lose weight, it is not yet clear… Continue Reading How new weight loss drugs will impact insurance premiums – Marketplace
WASHINGTON With blockbuster sales of Novo Nordisks Wegovy and Ozempic and the approval of a new rival this week, everyone in Washington is thinking about how to deal with the surging tide of weight-loss drug costs. Explosive national demand for weight management therapies and diabetes drugs like Ozempic, all of… Continue Reading Senator launches new models to manage costs of weight-loss drugs like Ozempic
Delta Air Lines, Pepsi, Philip Morris International and Darden Restaurants are among companies facing questions about the impact of GLP-1 on their bottom lines. In the United States, only a fraction of obese people currently take a GLP-1. That figure could rise to 13% by the end of the decade,… Continue Reading Wall Street is wondering what impact weight-loss drugs will have on consumer giants, but it may be too early to tell.
SINGAPORE Three people were hospitalized due to serious adverse reactions after taking drugs used to treat narcolepsy to improve alertness, the Health Sciences Authority (HSA) said on Monday (Nov 6). Those who suffer from narcolepsy have difficulty staying awake for long periods of time. The drugs in question, modafinil and… Continue Reading 3 people hospitalized after taking narcolepsy drugs as “cognitive enhancers” to improve alertness: HSA
Business By Shannon Thaler Published November 1, 2023, 12:10 p.m. ET Growing demand for Ozempic and Wegovy, made by Novo Nordisk, has fueled a rise in illegal sales of weight-loss drugs in Denmark, where the pharmaceutical company is based, the Danish Medicines Agency reported. The agency said in a statement… Continue Reading Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs
Growing demand for Ozempic and Wegovy, made by Novo Nordisk, has fueled a rise in illegal sales of weight-loss drugs in Denmark, where the pharmaceutical company is based, the Danish Medicines Agency reported. The agency said in a statement released Tuesday that authorities are aware of 26 websites illegally selling… Continue Reading Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs